BioCentury | Jul 25, 2019
Product Development

The universe of universal flu vaccines

...Codagenix Inc., Stony Brook, N.Y. CureVac AG, Tuebingen, Germany Emergent BioSolutions Inc. (NYSE:EBS), Gaithersburg, Md. Etubics Corp....
...Pong, Senior Writer, Research & Analytics Arecor Ltd. BiondVax Pharmaceuticals Ltd. Blue Water Vaccines Inc. Codagenix Inc. CureVac AG Emergent BioSolutions Inc. Etubics Corp. FluGen...
BioCentury | Jan 13, 2016
Politics & Policy

Coalition aims for cancer MoonShot

...include Amgen Inc. (NASDAQ:AMGN), Celgene Corp. (NASDAQ:CELG), NantKwest Inc. (NASDAQ:NK), NantWorks LLC (Los Angeles, Calif.), Etubics Corp....
BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...products delivered using adenoviral vectors in clinical development: Advantagene Inc. , Ascend Biopharmaceuticals Ltd. , Etubics Corp....
BioCentury | Jul 11, 2015
Company News

Management tracks

...company Aerie Pharmaceuticals Inc. (NASDAQ:AERI) said CMO Brian Levy has left the company. Immunotherapy company Etubics Corp....
BioCentury | Apr 15, 2013
Clinical News

Etubics preclinical data

...E6 and E7 antigens of HPV type 16. Data were published in Cancer Gene Therapy. Etubics...
...an IND to FDA in 1H13, with Phase I testing slated to begin in 2014. Etubics Corp....
BioCentury | May 28, 2012
Clinical News

ETBX-011: Phase I/II data

...will be presented at the American Society of Clinical Oncology meeting in Chicago in June. Etubics Corp....
BioCentury | Aug 22, 2011
Clinical News

Etubics preclinical data

...In mice challenged with a lethal dose of H1N1 influenza virus, vaccination with Etubics' adenovirus serotype...
...reduced viral titers in nasal washes compared to saline-treated controls. Data were published in Vaccine. Etubics Corp....
BioCentury | May 9, 2011
Clinical News

Etubics preclinical data

...In mice, vaccination with Etubics' breast cancer adenovirus serotype 5 (Ad5) vector vaccine containing the gene...
...tumors in both Ad5-naïve and Ad5-immune mice (p<0.001). Data were published in Cancer Gene Therapy. Etubics Corp....
BioCentury | Mar 7, 2011
Clinical News

ETBX-011: Phase II started

...trial to evaluate 3 immunization of subcutaneous ETBX-011 given every 3 weeks in 12 patients. Etubics Corp....
BioCentury | Oct 11, 2010
Clinical News

Etubics preclinical data

...In rhesus macaques, vaccination with Etubics' HIV adenovirus serotype 5 (Ad5) vector vaccine containing gag, pol...
...effects were observed following vaccination. Data were presented at the AIDS Vaccine meeting in Atlanta. Etubics Corp....
Items per page:
1 - 10 of 13
BioCentury | Jul 25, 2019
Product Development

The universe of universal flu vaccines

...Codagenix Inc., Stony Brook, N.Y. CureVac AG, Tuebingen, Germany Emergent BioSolutions Inc. (NYSE:EBS), Gaithersburg, Md. Etubics Corp....
...Pong, Senior Writer, Research & Analytics Arecor Ltd. BiondVax Pharmaceuticals Ltd. Blue Water Vaccines Inc. Codagenix Inc. CureVac AG Emergent BioSolutions Inc. Etubics Corp. FluGen...
BioCentury | Jan 13, 2016
Politics & Policy

Coalition aims for cancer MoonShot

...include Amgen Inc. (NASDAQ:AMGN), Celgene Corp. (NASDAQ:CELG), NantKwest Inc. (NASDAQ:NK), NantWorks LLC (Los Angeles, Calif.), Etubics Corp....
BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...products delivered using adenoviral vectors in clinical development: Advantagene Inc. , Ascend Biopharmaceuticals Ltd. , Etubics Corp....
BioCentury | Jul 11, 2015
Company News

Management tracks

...company Aerie Pharmaceuticals Inc. (NASDAQ:AERI) said CMO Brian Levy has left the company. Immunotherapy company Etubics Corp....
BioCentury | Apr 15, 2013
Clinical News

Etubics preclinical data

...E6 and E7 antigens of HPV type 16. Data were published in Cancer Gene Therapy. Etubics...
...an IND to FDA in 1H13, with Phase I testing slated to begin in 2014. Etubics Corp....
BioCentury | May 28, 2012
Clinical News

ETBX-011: Phase I/II data

...will be presented at the American Society of Clinical Oncology meeting in Chicago in June. Etubics Corp....
BioCentury | Aug 22, 2011
Clinical News

Etubics preclinical data

...In mice challenged with a lethal dose of H1N1 influenza virus, vaccination with Etubics' adenovirus serotype...
...reduced viral titers in nasal washes compared to saline-treated controls. Data were published in Vaccine. Etubics Corp....
BioCentury | May 9, 2011
Clinical News

Etubics preclinical data

...In mice, vaccination with Etubics' breast cancer adenovirus serotype 5 (Ad5) vector vaccine containing the gene...
...tumors in both Ad5-naïve and Ad5-immune mice (p<0.001). Data were published in Cancer Gene Therapy. Etubics Corp....
BioCentury | Mar 7, 2011
Clinical News

ETBX-011: Phase II started

...trial to evaluate 3 immunization of subcutaneous ETBX-011 given every 3 weeks in 12 patients. Etubics Corp....
BioCentury | Oct 11, 2010
Clinical News

Etubics preclinical data

...In rhesus macaques, vaccination with Etubics' HIV adenovirus serotype 5 (Ad5) vector vaccine containing gag, pol...
...effects were observed following vaccination. Data were presented at the AIDS Vaccine meeting in Atlanta. Etubics Corp....
Items per page:
1 - 10 of 13